Page last updated: 2024-11-04

bufalin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

bufalin: cardiotonic; powerful anesthetic & one of the active constituents of the Chinese drug ch'an su(senso); in Japan prepared from skin of Bufo bufo garfarizans; RN given refers to (3beta,5beta)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

bufalin : A 14beta-hydroxy steroid that is bufan-20,22-dienolide having hydroxy substituents at the 5beta- and 14beta-positions. It has been isolated from the skin of the toad Bufo bufo. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9547215
CHEMBL ID399680
CHEBI ID517248
SCHEMBL ID165666
MeSH IDM0079353

Synonyms (42)

Synonym
bufalin
AC-20197
LMST01130001
3beta,14beta-dihydroxy-5beta-bufa-20,22-dienolide
BRD-K63606607-001-02-6
BRD-K63606607-001-01-8
brn 5141601
bufa-20,22-dienolide, 3,14-dihydroxy-, (3beta,5beta)-
nsc 89595
5beta-bufa-20,22-dienolide, 3beta,14-dihydroxy-
bufa-20,22-dienolide, 3,14-dihydroxy-, (3-beta,5-beta)-
3-beta,14-dihydroxy-5-beta-bufa-20,22-dienolide
5-beta-bufa-20,22-dienolide, 3-beta,14-dihydroxy-
3,14-dihydroxy-bufa-20,22-dienolide
HSCI1_000110
SMP2_000290
CHEMBL399680
C16922
chebi:517248 ,
unii-u549s98qlw
ch'an su
u549s98qlw ,
bufalin: bufa-20,22-dienolide, 3,14-dihydroxy-, (3b,5b)-,
AKOS015965454
S7821
5-[(3s,5r,8r,9s,10s,13r,14s,17r)-3,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one
buf ,
SCHEMBL165666
CS-3694
AC-34068
bufalin [who-dd]
bufalin [mi]
HY-N0877
QEEBRPGZBVVINN-BMPKRDENSA-N
5-((3s,5r,8r,9s,10s,13r,14s,17r)-3,14-dihydroxy-10,13-dimethylhexadecahydro-1h-cyclopenta[a]phenanthren-17-yl)-2h-pyran-2-one
(3beta,5beta,10alpha,17alpha)-3,14-dihydroxybufa-20,22-dienolide
DTXSID90873563
BS-17080
Q18379323
bufa-20,22-dienolide, 3,14-dihydroxy-, (3b,5b)-
AMY40632
bdbm50584761

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Hence, an investigation of its toxicological mechanism is helpful for new drug development and treatment of the related clinical adverse reactions."( Bufalin-induced cardiotoxicity: new findings into mechanisms.
Li, H; Li, M; Ma, J; Wang, JX; Wang, XJ; Xing, HY; Zhang, XX; Zhang, YZ; Zhao, Q; Zhi, YY, 2020
)
0.56
" This work therefore presented a novel albumin polymer hybrid with favorable stability, efficient tumor-targeted delivery potential, and side effect reduction ability, which can be a potential vehicle for an anticancer drug."( Tumor-Targeted Delivery of Bufalin-Loaded Modified Albumin-Polymer Hybrid for Enhanced Antitumor Therapy and Attenuated Hemolysis Toxicity and Cardiotoxicity.
Chen, M; Chen, P; Shi, F; Tang, L; Wang, Y; Xu, Y; Zheng, M, 2021
)
0.62

Pharmacokinetics

ExcerptReferenceRelevance
"To determine the bufalin concentration in rats' plasma by establishing a high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method, and to evaluate and compare the pharmacokinetic characteristics of bufalin-loaded bovine serum albumin nanoparticles (bufalin-BSA-NP) and bufalin."( [A comparison study of pharmacokinetics between bufalin-loaded bovine serum albumin nanoparticles and bufalin in rats].
Jiang, ZQ; Sheng, JY; Su, YH; Wu, BY; Yin, ZF; Zhang, HQ, 2012
)
0.38
" The pharmacokinetic parameters were calculated and compared."( [A comparison study of pharmacokinetics between bufalin-loaded bovine serum albumin nanoparticles and bufalin in rats].
Jiang, ZQ; Sheng, JY; Su, YH; Wu, BY; Yin, ZF; Zhang, HQ, 2012
)
0.38

Compound-Compound Interactions

Bufalin (BUF) combined with doxorubicin (DOX) on the proliferation and apoptosis in human lung cancer cell line A549 in vitro. Results suggest that bufalin in combination with VP16, all-trans retinoic acid, 1 alpha,25-dihydroxyvitamin D3, rTNF-alpha, or gamma-interferon may be very useful in the differentiation of human leukemia.

ExcerptReferenceRelevance
" These results suggest that bufalin in combination with VP16, all-trans retinoic acid, 1 alpha,25-dihydroxyvitamin D3, rTNF-alpha, or gamma-interferon may be very useful in the differentiation of human leukemia."( Induction by bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers.
Kuroiwa, Y; Nakaya, K; Yoshida, T; Zhang, L, 1992
)
0.28
"To explore the effects of bufalin (BUF) combined with doxorubicin (DOX) on the proliferation and apoptosis in human lung cancer cell line A549 in vitro."( [Effects of bufalin combined with doxorubicin on the proliferation and apoptosis of human lung cancer cell line A549 in vitro].
Fu, L; Zhang, C, 2017
)
0.46
" In conclusion, the results revealed a synergistic anti-hepatoma effect of bufalin combined with sorafenib via affecting the tumor vascular microenvironment by targeting mTOR/VEGF signaling."( Synergistic anti-hepatoma effect of bufalin combined with sorafenib via mediating the tumor vascular microenvironment by targeting mTOR/VEGF signaling.
Chi, H; Meng, Z; Wang, H; Zhang, C, 2018
)
0.48

Bioavailability

ExcerptReferenceRelevance
" A bufalin SMEDDS was well absorbed at all intestinal segments."( An improved formulation screening and optimization method applied to the development of a self-microemulsifying drug delivery system.
Chen, ZQ; Feng, NP; Liu, Y; Tan, R; Wu, S; Zhang, X; Zhao, JH, 2010
)
0.36
" They could also improve drug bioavailability through the oral route."( Wheat germ agglutinin-grafted lipid nanoparticles: preparation and in vitro evaluation of the association with Caco-2 monolayers.
Chen, Z; Feng, N; Liu, Y; Sun, C; Tan, R; Wang, P; Wu, S; Yang, Y; Zhao, J; Zhou, W, 2010
)
0.36
" The performed cytotoxicity, cell apoptosis and pharmacokinetic experiments showed an enhanced bioavailability of BUF after encapsulation."( In situ phase transition of microemulsions for parenteral injection yielding lyotropic liquid crystalline carriers of the antitumor drug bufalin.
Angelova, A; Drechsler, M; Garamus, VM; Gong, Y; Li, N; Li, Y; Liu, J; Zou, A, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" In a single dosing study, the concentration of BF, CB and RB in plasma reached maximum at 1-2 hr after drug administration, and the half-lives (T1/2 of these were 15."( Metabolism and disposition of kyushin, a drug containing senso (ch'an su).
Morishita, S; Shimizu, Y, 1996
)
0.29
" High performance liquid chromatography coupled with the electrospray ionization mass spectrometry techniques of HPLC/ESI-IT-MS/MS and RRLC/ESI-Q-TOF-MS were used for the chemical profiling of samples of dosed plasma, control plasma and ChanSu extract."( Analysis of the bioactive constituents of ChanSu in rat plasma by high performance liquid chromatography with mass spectrometric detection.
Jin, H; Xia, X; Yan, S; Zhang, W, 2010
)
0.36
"Our progressive efforts that begin with preparation technology and dosage regimen enable BF211 to like a drug, providing a promising nano platform to deliver the cardiac glycosides and alleviate the side effects by decreasing unspecific biodistribution."( Surfactant Assisted Rapid-Release Liposomal Strategies Enhance the Antitumor Efficiency of Bufalin Derivative and Reduce Cardiotoxicity.
Chen, J; Gao, L; He, F; Hu, L; Li, S; Liu, Y; Ping, Q; Qiao, H; Wu, H; Zhang, L; Zhang, Y; Zhao, M, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
cardiotonic drugA drug that has a strengthening effect on the heart or that can increase cardiac output.
anti-inflammatory agentAny compound that has anti-inflammatory effects.
animal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in animals that include diverse creatures from sponges, insects to mammals.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
3beta-hydroxy steroidA 3-hydroxy steroid in which the 3-hydroxy substituent is in the beta-position.
14beta-hydroxy steroidA 14-hydroxy steroid in which the hydroxy group has a beta-configuration.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cytochrome P450 3A4Homo sapiens (human)IC50 (µMol)5.88000.00011.753610.0000AID1822700; AID1822703
Cytochrome P450 3A4Homo sapiens (human)Ki11.01500.00011.41629.9000AID1822717; AID1822718
Cytochrome P450 3A5Homo sapiens (human)IC50 (µMol)2.76000.00330.70736.2000AID1822701
Cytochrome P450 3A7Homo sapiens (human)IC50 (µMol)100.00000.01402.75806.2000AID1822702
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (20)

Processvia Protein(s)Taxonomy
lipid hydroxylationCytochrome P450 3A4Homo sapiens (human)
lipid metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid catabolic processCytochrome P450 3A4Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid metabolic processCytochrome P450 3A4Homo sapiens (human)
cholesterol metabolic processCytochrome P450 3A4Homo sapiens (human)
androgen metabolic processCytochrome P450 3A4Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A4Homo sapiens (human)
alkaloid catabolic processCytochrome P450 3A4Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 3A4Homo sapiens (human)
calcitriol biosynthetic process from calciolCytochrome P450 3A4Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D metabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D catabolic processCytochrome P450 3A4Homo sapiens (human)
retinol metabolic processCytochrome P450 3A4Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A4Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 3A4Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 3A4Homo sapiens (human)
oxidative demethylationCytochrome P450 3A4Homo sapiens (human)
lipid hydroxylationCytochrome P450 3A5Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A5Homo sapiens (human)
steroid metabolic processCytochrome P450 3A5Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A5Homo sapiens (human)
alkaloid catabolic processCytochrome P450 3A5Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 3A5Homo sapiens (human)
retinol metabolic processCytochrome P450 3A5Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A5Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 3A5Homo sapiens (human)
oxidative demethylationCytochrome P450 3A5Homo sapiens (human)
lipid hydroxylationCytochrome P450 3A7Homo sapiens (human)
steroid biosynthetic processCytochrome P450 3A7Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A7Homo sapiens (human)
steroid metabolic processCytochrome P450 3A7Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A7Homo sapiens (human)
retinol metabolic processCytochrome P450 3A7Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A7Homo sapiens (human)
oxidative demethylationCytochrome P450 3A7Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (24)

Processvia Protein(s)Taxonomy
monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
steroid bindingCytochrome P450 3A4Homo sapiens (human)
iron ion bindingCytochrome P450 3A4Homo sapiens (human)
protein bindingCytochrome P450 3A4Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
oxidoreductase activityCytochrome P450 3A4Homo sapiens (human)
oxygen bindingCytochrome P450 3A4Homo sapiens (human)
enzyme bindingCytochrome P450 3A4Homo sapiens (human)
heme bindingCytochrome P450 3A4Homo sapiens (human)
vitamin D3 25-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
caffeine oxidase activityCytochrome P450 3A4Homo sapiens (human)
quinine 3-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
aromatase activityCytochrome P450 3A4Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1,8-cineole 2-exo-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
monooxygenase activityCytochrome P450 3A5Homo sapiens (human)
iron ion bindingCytochrome P450 3A5Homo sapiens (human)
protein bindingCytochrome P450 3A5Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A5Homo sapiens (human)
oxidoreductase activityCytochrome P450 3A5Homo sapiens (human)
oxygen bindingCytochrome P450 3A5Homo sapiens (human)
heme bindingCytochrome P450 3A5Homo sapiens (human)
aromatase activityCytochrome P450 3A5Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A5Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A5Homo sapiens (human)
monooxygenase activityCytochrome P450 3A7Homo sapiens (human)
iron ion bindingCytochrome P450 3A7Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 3A7Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A7Homo sapiens (human)
oxygen bindingCytochrome P450 3A7Homo sapiens (human)
heme bindingCytochrome P450 3A7Homo sapiens (human)
all-trans retinoic acid 18-hydroxylase activityCytochrome P450 3A7Homo sapiens (human)
aromatase activityCytochrome P450 3A7Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A7Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 3A7Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A7Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
cytoplasmCytochrome P450 3A4Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A4Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 3A4Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A5Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 3A5Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A7Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (154)

Assay IDTitleYearJournalArticle
AID1423228Cytotoxicity against human LoVo cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID310227Cytotoxicity against human HepG2 cells2007Bioorganic & medicinal chemistry letters, Nov-15, Volume: 17, Issue:22
Microbial transformation of three bufadienolides by Nocardia sp. and some insight for the cytotoxic structure-activity relationship (SAR).
AID1423252Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 1.6 nM after 24 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID127349Binding affinity against human monoclonal antibody (mAb)-11E62002Journal of medicinal chemistry, Jul-18, Volume: 45, Issue:15
Three-dimensional quantitative structure-activity relationship analysis of ligand binding to human sequence antidigoxin monoclonal antibodies using comparative molecular field analysis.
AID1822690Time dependent inhibition of CYP3A in human liver microsomes using N-ethyl-1,8-naphthalimide as substrate preincubated for 30 mins in presence of NADPH generating system followed by substrate addition incubated for 10 mins by microplate reader analysis2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A.
AID1423253Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 1.6 nM after 36 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1423264Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 40 nM after 48 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID333789Growth inhibition of IL6-dependent mouse MH60 cells after 72 hrs by MTT assay in presence of human recombinant IL62004Journal of natural products, Dec, Volume: 67, Issue:12
Inhibitory effects of bufadienolides on interleukin-6 in MH-60 cells.
AID1423214Cytotoxicity against human SKOV3 cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID759509Cytotoxicity against human HepG2 cells assessed as growth inhibition after 48 hrs by MTT assay2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID759476Activation of ClC-3 in human CNE2Z cells assessed as decrease in phosphorylation of Akt at Thr308 at 1 uM after 24 hrs by Western blot analysis2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID759480Induction of apoptosis in human CNE2Z cells assessed as expression of caspase-3 at 1 uM after 24 hrs by annexin V-FITC/propidium iodide staining-based flow cytometric analysis in presence of tamoxifen, NPPB, ClC-3 siRNA2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID759498Cell cycle arrest in human CNE2Z cells assessed as accumulation at sub-G1 phase at 10 uM after 24 hrs by propidium iodide staining-based flow cytometric analysis in presence of tamoxifen (Rvb = 1.5%)2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1423227Cytotoxicity against human BxPC3 cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1423237Cytotoxicity against human MRC5 cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID759493Cell cycle arrest in human CNE2Z cells assessed as accumulation at sub-G1 phase at 5 uM after 24 hrs by propidium iodide staining-based flow cytometric analysis in presence of ClC-3 siRNA (Rvb = 1.3%)2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1423251Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 1.6 nM after 12 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID155910Inhibitory activity against the primary liver carcinoma (PLC) cell line PLC/PRF/52002Journal of medicinal chemistry, Dec-05, Volume: 45, Issue:25
QSAR evaluation of the Ch'an Su and related bufadienolides against the colchicine-resistant primary liver carcinoma cell line PLC/PRF/5(1).
AID759467Activation of ClC-3 in human CNE2Z cells assessed as decrease in phosphorylation of m-TOR at ser2481 at 1 uM after 24 hrs by Western blot analysis in presence of ClC-3 siRNA2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1423259Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 8 nM after 24 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1423230Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1423217Cytotoxicity against human HepG2 cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID759462Activation of ClC-3 in human CNE2Z cells assessed as increase in chloride current in outward and inward direction at +80mV holding potential at 1 uM by whole-cell patch clamp method2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1822722Inactivation of recombinant human CYP3A4 at 1 uM for 15 mins relative to control2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A.
AID759482Induction of apoptosis in human CNE2Z cells assessed as increase in apoptotic cell level at 1 to 10 uM after 24 hrs by annexin V-FITC/propidium iodide staining-based flow cytometric analysis in presence of tamoxifen, NPPB, ClC-3 siRNA2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID759504Cytotoxicity against SV40-transformed human NP69 cells assessed as cell viability after 48 hrs by MTT assay2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1423226Cytotoxicity against human MCF7 cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID127351Binding affinity against human monoclonal antibody (mAb)-5C22002Journal of medicinal chemistry, Jul-18, Volume: 45, Issue:15
Three-dimensional quantitative structure-activity relationship analysis of ligand binding to human sequence antidigoxin monoclonal antibodies using comparative molecular field analysis.
AID1822702Time dependent inhibition of recombinant human CYP3A7 incubated for 30 mins in presence of NADPH generating system by LC-MS/MS analysis2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A.
AID1423233Cytotoxicity against human NCI-H1975 cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1423243Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 0.32 nM after 4 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID759465Cytotoxicity against mouse S180 cells expressing mutated alpha-1 Na+/K+-ATPase assessed as growth inhibition after 48 hrs by MTT assay2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1822701Time dependent inhibition of recombinant human CYP3A5 incubated for 30 mins in presence of NADPH generating system by LC-MS/MS analysis2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A.
AID1423231Cytotoxicity against human NCI-N87 cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1364315Inhibition of Na/K-ATPase in pig kidney microsomal membranes assessed as reduction in inorganic phosphate release from ATP at 25 uM incubated for 15 mins by spectrophotometry2017Journal of natural products, 04-28, Volume: 80, Issue:4
Bufospirostenin A and Bufogargarizin C, Steroids with Rearranged Skeletons from the Toad Bufo bufo gargarizans.
AID759473Activation of ClC-3 in human CNE2Z cells assessed as decrease in phosphorylation of m-TOR at ser2481 at 1 uM after 24 hrs by Western blot analysis2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1423266Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 8 nM after 8 mins2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID773796Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay2013Journal of natural products, Oct-25, Volume: 76, Issue:10
C23 steroids from the venom of Bufo bufo gargarizans.
AID1822686Ratio of IC50 for time dependent inhibition of recombinant human CYP3A4 incubated for 30 mins by LC-MS/MS analysis to IC50 for time dependent inhibition of recombinant human CYP3A4 using midazolam as substrate preincubated for 30 mins in presence of NADPH2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A.
AID759478Activation of ClC-3 in human CNE2Z cells assessed as decrease in PI3K P110alpha level at 1 uM after 24 hrs by Western blot analysis2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1423268Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as increase in beating amplitude at >40 nM2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1423216Cytotoxicity against human HCT116 cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1423224Cytotoxicity against human THP1 cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID310229Cytotoxicity against human BGC823 cells2007Bioorganic & medicinal chemistry letters, Nov-15, Volume: 17, Issue:22
Microbial transformation of three bufadienolides by Nocardia sp. and some insight for the cytotoxic structure-activity relationship (SAR).
AID1423213Cytotoxicity against human BT474 cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID155909Inhibitory activity against colchicine resistant parent primary liver carcinoma (PLC) cell line PLC/PRF/52002Journal of medicinal chemistry, Dec-05, Volume: 45, Issue:25
QSAR evaluation of the Ch'an Su and related bufadienolides against the colchicine-resistant primary liver carcinoma cell line PLC/PRF/5(1).
AID1822694Time dependent inhibition of CYP2D6 in human liver microsomes assessed as enzyme remaining activity at 10 to 100 uM using N-ethyl-1,8-naphthalimide as substrate preincubated for 30 mins in presence of NADPH generating system followed by substrate addition2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A.
AID759466Activation of ClC-3 in human CNE2Z cells assessed as decrease in phosphorylation of Akt at Thr308 at 1 uM after 24 hrs by Western blot analysis in presence of ClC-3 siRNA2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1423220Cytotoxicity against human MESSA cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID759506Activation of ClC-3 in human CNE2Z cells assessed as increase in chloride current density at +80mV holding potential at 1 uM by whole-cell patch clamp method relative to vehicle-treated control2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID357628Cytotoxicity against human KB cells after 72 hrs by MTT assay2001Journal of natural products, Sep, Volume: 64, Issue:9
Isolation and structure of five new cancer cell growth inhibitory bufadienolides from the Chinese traditional drug Ch'an Su.
AID1423229Cytotoxicity against human LOX cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID759494Cell cycle arrest in human CNE2Z cells assessed as accumulation at sub-G1 phase at 1 uM after 24 hrs by propidium iodide staining-based flow cytometric analysis in presence of ClC-3 siRNA (Rvb = 1.3%)2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1421806Induction of apoptosis in human HeLa cells assessed as necrotic cells at 200 nM after 24 hrs by Annexin-V-FITC/propidium iodide staining based flow cytometry (Rvb = 0.031%)2018European journal of medicinal chemistry, Oct-05, Volume: 158A cardiac glycoside HTF-1 isolated from Helleborus thibetanus Franch displays potent in vitro anti-cancer activity via caspase-9, MAPK and PI3K-Akt-mTOR pathways.
AID1822692Time dependent inhibition of CYP2A6 in human liver microsomes assessed as enzyme remaining activity at 10 to 100 uM using N-ethyl-1,8-naphthalimide as substrate preincubated for 30 mins in presence of NADPH generating system followed by substrate addition2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A.
AID759481Induction of apoptosis in human CNE2Z cells assessed as induction of PARP cleavage at 1 uM after 24 hrs by annexin V-FITC/propidium iodide staining-based flow cytometric analysis in presence of tamoxifen, NPPB, ClC-3 siRNA2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1423262Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 40 nM after 33 mins2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1423267Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 40 nM after 8 mins2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1822718Inactivation of recombinant human CYP3A4 assessed as inhibition constant using midazolam as substrate preincubated for 5 mins followed by beta-NADP addition for 15 mins and midazolam addition after 10 mins in presence of NADPH-generating system by LC-MS/M2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A.
AID759502Cell cycle arrest in human CNE2Z cells assessed as accumulation at sub-G1 phase at 5 uM after 24 hrs by propidium iodide staining-based flow cytometric analysis (Rvb = 1.1%)2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID759489Induction of apoptosis in human CNE2Z cells assessed as activation of caspase-3 at 1 uM after 24 hrs by annexin V-FITC/propidium iodide staining-based flow cytometric analysis2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1423247Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 0.32 nM after 48 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID759500Cell cycle arrest in human CNE2Z cells assessed as accumulation at sub-G1 phase at 1 uM after 24 hrs by propidium iodide staining-based flow cytometric analysis in presence of tamoxifen (Rvb = 1.5%)2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID759491Induction of apoptosis in human CNE2Z cells assessed as increase in apoptotic cell level at 1 to 10 uM after 24 hrs by annexin V-FITC/propidium iodide staining-based flow cytometric analysis2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID759474Activation of ClC-3 in human CNE2Z cells assessed as decrease in phosphorylation of m-TOR at ser2448 at 1 uM after 24 hrs by Western blot analysis2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1421781Cytotoxicity activity against human HeLa cells after 24 hrs by MTT assay2018European journal of medicinal chemistry, Oct-05, Volume: 158A cardiac glycoside HTF-1 isolated from Helleborus thibetanus Franch displays potent in vitro anti-cancer activity via caspase-9, MAPK and PI3K-Akt-mTOR pathways.
AID1423254Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 1.6 nM after 48 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1421804Induction of apoptosis in human HeLa cells assessed as early apoptotic cells at 200 nM after 24 hrs by Annexin-V-FITC/propidium iodide staining based flow cytometry (Rvb = 3.08%)2018European journal of medicinal chemistry, Oct-05, Volume: 158A cardiac glycoside HTF-1 isolated from Helleborus thibetanus Franch displays potent in vitro anti-cancer activity via caspase-9, MAPK and PI3K-Akt-mTOR pathways.
AID1423241Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 0.32 nM after 33 mins2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1822703Time dependent inhibition of recombinant human CYP3A4 using midazolam as substrate preincubated for 30 mins in presence of NADPH generating system followed by substrate addition incubated for 30 mins by LC-MS/MS analysi2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A.
AID1423236Cytotoxicity against human HUVEC cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1421803Induction of apoptosis in human HeLa cells assessed as viable cells at 200 nM after 24 hrs by Annexin-V-FITC/propidium iodide staining based flow cytometry (Rvb = 85.8%)2018European journal of medicinal chemistry, Oct-05, Volume: 158A cardiac glycoside HTF-1 isolated from Helleborus thibetanus Franch displays potent in vitro anti-cancer activity via caspase-9, MAPK and PI3K-Akt-mTOR pathways.
AID773793Cytotoxicity against KM mouse splenic lymphocytes assessed as cell viability at 5 uM2013Journal of natural products, Oct-25, Volume: 76, Issue:10
C23 steroids from the venom of Bufo bufo gargarizans.
AID759497Cell cycle arrest in human CNE2Z cells assessed as accumulation at sub-G1 phase at 1 uM after 24 hrs by propidium iodide staining-based flow cytometric analysis in presence of NPPB (Rvb = 2%)2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1423261Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 8 nM after 48 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1423232Cytotoxicity against human A549 cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1423250Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 1.6 nM after 4 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID310228Cytotoxicity against human HeLa cells2007Bioorganic & medicinal chemistry letters, Nov-15, Volume: 17, Issue:22
Microbial transformation of three bufadienolides by Nocardia sp. and some insight for the cytotoxic structure-activity relationship (SAR).
AID773795Cytotoxicity against human A549 cells after 24 hrs by MTT assay2013Journal of natural products, Oct-25, Volume: 76, Issue:10
C23 steroids from the venom of Bufo bufo gargarizans.
AID1423248Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 1.6 nM after 33 mins2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1423218Cytotoxicity against human DU145 cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID759468Activation of ClC-3 in human CNE2Z cells assessed as decrease in phosphorylation of m-TOR at ser2448 at 1 uM after 24 hrs by Western blot analysis in presence of ClC-3 siRNA2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID759472Activation of ClC-3 in human CNE2Z cells assessed as decrease in PI3K P110alpha level at 1 uM after 24 hrs by Western blot analysis in presence of ClC-3 siRNA2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1423258Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 8 nM after 12 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1822689Time dependent inhibition of CYP3A in human liver microsomes assessed as enzyme remaining activity at 10 uM using N-ethyl-1,8-naphthalimide as substrate preincubated for 30 mins in presence of NADPH generating system followed by substrate addition and inc2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A.
AID759464Cytotoxicity against mouse H22 cells expressing mutated alpha-1 Na+/K+-ATPase assessed as growth inhibition after 48 hrs by MTT assay2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1423239Cytotoxicity against mouse S180 cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID357629Cytotoxicity against human HL60 cells after 72 hrs by MTT assay2001Journal of natural products, Sep, Volume: 64, Issue:9
Isolation and structure of five new cancer cell growth inhibitory bufadienolides from the Chinese traditional drug Ch'an Su.
AID1423260Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 8 nM after 36 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1364314Inhibition of Na/K-ATPase in pig kidney microsomal membranes assessed as reduction in inorganic phosphate release from ATP at 12.5 uM incubated for 15 mins by spectrophotometry2017Journal of natural products, 04-28, Volume: 80, Issue:4
Bufospirostenin A and Bufogargarizin C, Steroids with Rearranged Skeletons from the Toad Bufo bufo gargarizans.
AID759505Activation of ClC-3 in human CNE2Z cells assessed as increase in chloride current in outward and inward direction at +80mV holding potential at 1 uM by whole-cell patch clamp method in presence of NPPB and tamoxifen2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID759501Cell cycle arrest in human CNE2Z cells assessed as accumulation at sub-G1 phase at 10 uM after 24 hrs by propidium iodide staining-based flow cytometric analysis (Rvb = 1.1%)2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1822720Inactivation of recombinant human CYP3A4 assessed as inactivation constant using midazolam as substrate preincubated for 5 mins followed by beta-NADP addition for 15 mins and midazolam addition after 10 mins in presence of NADPH-generating system by LC-MS2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A.
AID1423222Cytotoxicity against human 786-O cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1822698Time dependent inhibition of CYP3A in human liver microsomes incubated for 30 mins in presence of NADPH generating system by LC-MS/MS analysis2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A.
AID357630Cytotoxicity against mouse MH60 cells after 72 hrs by MTT assay2001Journal of natural products, Sep, Volume: 64, Issue:9
Isolation and structure of five new cancer cell growth inhibitory bufadienolides from the Chinese traditional drug Ch'an Su.
AID759475Activation of ClC-3 in human CNE2Z cells assessed as decrease in m-TOR level at 1 uM after 24 hrs by Western blot analysis2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID759471Activation of ClC-3 in human CNE2Z cells assessed as decrease in Akt level at 1 uM after 24 hrs by Western blot analysis in presence of ClC-3 siRNA2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1423225Cytotoxicity against human HeLa cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1822719Inactivation of CYP3A4 in human liver microsomes assessed as inactivation constant using midazolam as substrate preincubated for 5 mins followed by beta-NADP addition for 15 mins and midazolam addition after 10 mins in presence of NADPH-generating system 2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A.
AID1423256Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 8 nM after 66 mins2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1822706Ratio of IC50 for time dependent inhibition of recombinant human CYP3A5 incubated for 30 mins by LC-MS/MS analysis to IC50 for time dependent inhibition of recombinant human CYP3A5 using midazolam as substrate preincubated for 30 mins in presence of NADPH2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A.
AID759496Cell cycle arrest in human CNE2Z cells assessed as accumulation at sub-G1 phase at 5 uM after 24 hrs by propidium iodide staining-based flow cytometric analysis in presence of NPPB (Rvb = 2%)2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID759470Activation of ClC-3 in human CNE2Z cells assessed as decrease in phosphorylation of Akt at ser473 at 1 uM after 24 hrs by Western blot analysis in presence of ClC-3 siRNA2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1822721Inhibition of CYP3A in human liver microsomes at 10 uM using midazolam as substrate incubated for 10 mins relative to control2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A.
AID1421782Cytotoxicity activity against human HeLa cells after 48 hrs by MTT assay2018European journal of medicinal chemistry, Oct-05, Volume: 158A cardiac glycoside HTF-1 isolated from Helleborus thibetanus Franch displays potent in vitro anti-cancer activity via caspase-9, MAPK and PI3K-Akt-mTOR pathways.
AID759492Cell cycle arrest in human CNE2Z cells assessed as accumulation at sub-G1 phase at 10 uM after 24 hrs by propidium iodide staining-based flow cytometric analysis in presence of ClC-3 siRNA (Rvb = 1.3%)2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1822699Time dependent inhibition of CYP3A in human liver microsomes using midazolam as substrate preincubated for 30 mins in presence of NADPH generating system followed by substrate addition incubated for 30 mins by LC-MS/MS analysi2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A.
AID759511Cell cycle arrest in human CNE2Z cells assessed as accumulation at sub-G1 phase at 1 uM after 24 hrs by propidium iodide staining-based flow cytometric analysis (Rvb = 1.1%)2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID333788Growth inhibition of IL-6-independent mouse MH60 cells after 72 hrs by MTT assay2004Journal of natural products, Dec, Volume: 67, Issue:12
Inhibitory effects of bufadienolides on interleukin-6 in MH-60 cells.
AID401629Cytotoxicity against human BGC823 cells after 72 hrs by MTT assay2005Journal of natural products, Apr, Volume: 68, Issue:4
Microbial hydroxylation of bufalin by Cunninghamella blakesleana and Mucor spinosus.
AID1822700Time dependent inhibition of recombinant human CYP3A4 incubated for 30 mins in presence of NADPH generating system by LC-MS/MS analysis2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A.
AID1423265Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 1.6 nM after 8 mins2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1423244Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 0.32 nM after 12 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1822687Ratio of IC50 for time dependent inhibition of CYP3A in human liver microsomes incubated for 30 mins by LC-MS/MS analysis to IC50 for time dependent inhibition of CYP3A in human liver microsomes using midazolam as substrate preincubated for 30 mins in pre2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A.
AID1423263Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 40 nM after 66 mins2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID759510Cytotoxicity against human CNE1 cells assessed as growth inhibition after 48 hrs by MTT assay2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID127352Binding affinity against human monoclonal antibody (mAb)-7F22002Journal of medicinal chemistry, Jul-18, Volume: 45, Issue:15
Three-dimensional quantitative structure-activity relationship analysis of ligand binding to human sequence antidigoxin monoclonal antibodies using comparative molecular field analysis.
AID1423242Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 0.32 nM after 66 mins2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID759499Cell cycle arrest in human CNE2Z cells assessed as accumulation at sub-G1 phase at 5 uM after 24 hrs by propidium iodide staining-based flow cytometric analysis in presence of tamoxifen (Rvb = 1.5%)2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1822695Time dependent inhibition of CYP2E1 in human liver microsomes assessed as enzyme remaining activity at 10 to 100 uM using N-ethyl-1,8-naphthalimide as substrate preincubated for 30 mins in presence of NADPH generating system followed by substrate addition2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A.
AID759507Cytotoxicity against adriamycin-resistant human HepG2 cells assessed as growth inhibition after 48 hrs by MTT assay2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1423238Cytotoxicity against mouse H22 cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1822709Ratio of IC50 for time dependent inhibition of recombinant human CYP3A7 incubated for 30 mins by LC-MS/MS analysis to IC50 for time dependent inhibition of recombinant human CYP3A7 using midazolam as substrate preincubated for 30 mins in presence of NADPH2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A.
AID1423234Cytotoxicity against human MV411 cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1423245Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 0.32 nM after 24 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1423215Cytotoxicity against human PANC1 cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID759495Cell cycle arrest in human CNE2Z cells assessed as accumulation at sub-G1 phase at 10 uM after 24 hrs by propidium iodide staining-based flow cytometric analysis in presence of NPPB (Rvb = 2%)2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1423255Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 8 nM after 33 mins2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1822691Time dependent inhibition of CYP1A in human liver microsomes assessed as enzyme remaining activity at 10 to 100 uM using N-ethyl-1,8-naphthalimide as substrate preincubated for 30 mins in presence of NADPH generating system followed by substrate addition 2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A.
AID127350Binding affinity against human monoclonal antibody (mAb)-1B32002Journal of medicinal chemistry, Jul-18, Volume: 45, Issue:15
Three-dimensional quantitative structure-activity relationship analysis of ligand binding to human sequence antidigoxin monoclonal antibodies using comparative molecular field analysis.
AID1423257Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 8 nM after 4 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID401628Cytotoxicity against human Bel7402 cells after 72 hrs by MTT assay2005Journal of natural products, Apr, Volume: 68, Issue:4
Microbial hydroxylation of bufalin by Cunninghamella blakesleana and Mucor spinosus.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1423223Cytotoxicity against human Daudi cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1421805Induction of apoptosis in human HeLa cells assessed as late apoptotic cells at 200 nM after 24 hrs by Annexin-V-FITC/propidium iodide staining based flow cytometry (Rvb = 11.1%)2018European journal of medicinal chemistry, Oct-05, Volume: 158A cardiac glycoside HTF-1 isolated from Helleborus thibetanus Franch displays potent in vitro anti-cancer activity via caspase-9, MAPK and PI3K-Akt-mTOR pathways.
AID1822693Time dependent inhibition of CYP2C9 in human liver microsomes assessed as enzyme remaining activity at 10 to 100 uM using N-ethyl-1,8-naphthalimide as substrate preincubated for 30 mins in presence of NADPH generating system followed by substrate addition2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A.
AID759477Activation of ClC-3 in human CNE2Z cells assessed as decrease in phosphorylation of Akt at ser473 at 1 uM after 24 hrs by Western blot analysis2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1423235Cytotoxicity against human MDA-MB-468 cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID773797Inhibition of Na(+)/K(+) ATPase in pig cerebral cortex assessed as release of inorganic phosphate after 15 mins by colorimetric method2013Journal of natural products, Oct-25, Volume: 76, Issue:10
C23 steroids from the venom of Bufo bufo gargarizans.
AID759469Activation of ClC-3 in human CNE2Z cells assessed as decrease in m-TOR level at 1 uM after 24 hrs by Western blot analysis in presence of ClC-3 siRNA2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID759490Induction of apoptosis in human CNE2Z cells assessed as induction of PARP cleavage at 1 uM after 24 hrs by annexin V-FITC/propidium iodide staining-based flow cytometric analysis2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID759508Cytotoxicity against human CNE2Z cells assessed as growth inhibition after 48 hrs by MTT assay2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID759503Upregulation of ClC-3 protein expression in human CNE2Z cells after 24 hrs by Western blot analysis2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID759479Activation of ClC-3 in human CNE2Z cells assessed as decrease in Akt level at 1 uM after 24 hrs by Western blot analysis2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1423249Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 1.6 nM after 66 mins2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID401630Cytotoxicity against human HeLa cells after 72 hrs by MTT assay2005Journal of natural products, Apr, Volume: 68, Issue:4
Microbial hydroxylation of bufalin by Cunninghamella blakesleana and Mucor spinosus.
AID759463Activation of ClC-3 in SV40-transformed human NP69 cells assessed as increase in chloride current density at +80mV holding potential at 1 uM by whole-cell patch clamp method2013Journal of medicinal chemistry, Jul-25, Volume: 56, Issue:14
Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
AID1423221Cytotoxicity against human MES-SA/Dx5 cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1423240Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 0.32 nM after 8 mins2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1822717Inactivation of CYP3A4 in human liver microsomes assessed as inhibition constant using midazolam as substrate preincubated for 5 mins followed by beta-NADP addition for 15 mins and midazolam addition after 10 mins in presence of NADPH-generating system by2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A.
AID1423219Cytotoxicity against human HT1080 cells assessed as decrease in cell viability after 72 hrs by MTS assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
AID1423246Toxicity in human inducible pluripotent stem cell derived cardiomyocytes assessed as change in beating amplitude at 0.32 nM after 36 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (326)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (1.53)18.7374
1990's56 (17.18)18.2507
2000's52 (15.95)29.6817
2010's161 (49.39)24.3611
2020's52 (15.95)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews8 (2.40%)6.00%
Case Studies3 (0.90%)4.05%
Observational0 (0.00%)0.25%
Other322 (96.70%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]